Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guangdong Zhongpeng Pharmaceutical is a prominent Chinese pharmaceutical company specializing in the research, development, and large-scale manufacturing of chemical APIs and finished dosage forms. Established in 1993 and headquartered in Shantou, the company operates multiple GMP-certified production lines focusing on therapeutic areas such as anti-infectives, cardiovascular diseases, and gastrointestinal disorders. Zhongpeng is recognized as a national high-tech enterprise and maintains a robust portfolio of essential medicines, including widely used antibiotics like Cefixime and Azithromycin. In addition to its domestic commercial operations, the company provides contract manufacturing services and engages in the development of improved drug formulations to meet evolving healthcare needs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhongpeng.